← All patents

US20240293459A1

Peptides and engineered t cell receptors targeting sars-cov-2 antigens and …

University of Texas System

Abstract

This disclosure provides for peptides useful for vaccination and other applications, engineered T cell Receptors (TCRs), cells comprising the peptides and TCRs, and methods of making and using the peptides and TCRs. The current disclosure relates to TCRs that specifically recognize SARS-Cov-2 HLA- …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Cassian Yee
Priority date
March 29, 2021
Filing date
March 29, 2022
Publication date
September 05, 2024
Language
en
Metadata fetched
August 29, 2026 00:31